When you think about UKV PLC, the first thing that comes to mind is wine investment. The company is known for being one of the top experts in the wine industry. Their team of experienced and dedicated consultants offers services ranging from marketing a wine selling business to choosing fine wine or champagne for an important occasion.
One of the things which set apart the team at UKV PLC apart from the rest of the wine experts in the country is that they have unbeatable knowledge in what they do. On top of that, they design their services to fit the individual and unique needs of their clients. For instance, if you prefer consultancy services offered at the comfort of your home, a consultant from UKV PLC can come to you. They have helped many clients make the right choice when it comes to fine wine and champagne selection.
Follow UKV PLC on Twitter
Apart from offering consultancy services, UKV PLC is also involved in investment. Because they work with numerous suppliers and merchants, their advice on wine and how to invest in the sector is unbiased. The company also offers brokerage services to those traders who wish to start small. They trade on behalf of both seasoned trade customers as well as private individuals.
With the company’s large network of suppliers and traders, UKV PLC has created a niche for itself in the wine investment sector. Whether you want regular wine or unique champagne options for an upcoming event, be sure you will find it in stock. The best way of finding out what options they have, visit the UKV PLC official website. On their website, they have wine and champagne varieties which come in different prices. You can buy your wine online and the team will deliver to you.
Dr. Jim Tananbaum is the founding CEO of the Foresite Capital. This is a healthcare venture and a dedicated private equity firm that specializes in identifying emerging healthcare leaders and helping to boost their profitability by supplying information, advice, capital, and networks. The firm has more than 1.1 billion dollars in assets under management. The idea of starting Foresite Capital came in 2011. Jim had more than 25 years of experience as an entrepreneur and investments strategist in the healthcare industry. His focus is on strategic, operational, and financial opportunities to build franchise healthcare investments. Foresite Capital has invested in more than 77 different healthcare companies in Biopharmaceuticals, medical services & devices, diagnostics, and genomic sequencing. More details can be found on Crunchbase.
Dr. Jim Tananbaum holds a Master’s degree in Business Administration and M.D Degree from the Harvard Business School. He also holds a Master’s of Science from Massachusetts Institute of Technology. He has vast experience in the healthcare sector through investing and building healthcare companies. Jim is a former senior director at Illumina. He led investments in 21 successful healthcare companies including Amira Pharmaceuticals, Amerigroup group, and Jazz Pharmaceuticals. He previously founded and was the CEO of Thieravance, Inc. (NASDAQ: THRX). Jim founded GelTex Pharmaceuticals (NASDAQ: GENZ) after finishing Harvard Medical School. It was able to bring two drugs to the market for less than 80 million dollars. The drugs generate 1 billion dollars in revenues today. Thieravance and Biopharma, Inc. have a combined market cap of 2.75 billion dollars. It was later acquired at 1.6 billion dollars by Genzyme and Thieravance.
Dr. Jim Tananbaum was a founding partner of Prospect Venture Partners II and III. He was also a partner at Sierra Ventures where he was involved in helping to establish their healthcare services investment practice. Dr. Tananbaum has served on advisory boards and visiting committees to the Harvard-MIT HST program and Yale’s President Advisory Council. He is named among the top 100 best venture investors by Forbes Midas list for the third consecutive year due to several major healthcare investments. The Midas List recognizes the top 100 venture capitalists who lead in tech enterprises of the future and who create exceptional value for their investors.
Click here: https://www.linkedin.com/in/jim-tananbaum-a7562a7/